United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2017_register executive 2017-11-28 article Notices D09002ee1c7ef5a67 D09002ee1c7ef5c62 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States Food and Drug Administration originator org United States Government Agency or Subagency The Food and Drug Administration (FDA) is announcing the following public workshop entitled "Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology." The purpose of the public workshop is to engage stakeholders and solicit input from experts in oncology precision medicine on how to best weigh and evaluate evidence for classification and interpretation of sequencing results for precision oncology. 82 FR 56245 https://www.govinfo.gov/app/details/FR-2017-11-28/2017-25584 2017-25584 fr28no17-71 4164-01-P Docket No. FDA-2017-N-0001 https://www.govinfo.gov/app/details/FR-2017-11-28/2017-25584 https://www.govinfo.gov/content/pkg/FR-2017-11-28/html/2017-25584.htm https://www.govinfo.gov/content/pkg/FR-2017-11-28/pdf/2017-25584.pdf 2 p. 56245 56246 82 FR 56245 Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology; Public Workshop; Federal Register Vol. 82, Issue NOTICE 2017-25584 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Docket No. FDA-2017-N-0001 4164-01-P 2017-25584 Notice of public workshop.

The Food and Drug Administration (FDA) is announcing the following public workshop entitled "Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology." The purpose of the public workshop is to engage stakeholders and solicit input from experts in oncology precision medicine on how to best weigh and evaluate evidence for classification and interpretation of sequencing results for precision oncology.

The public workshop will be held on January 29, 2018, from 8:30 a.m. to 5 p.m. See the SUPPLEMENTARY INFORMATION section for registration date and information. Hisani Madison, Food and Drug Administration, Center for Devices and Radiological Health, 10903 New Hampshire Ave., Bldg. 66, Rm. 5547, Silver Spring, MD 20993, 240-402- 6581, hisani.madison@fda.hhs.gov. Meetings: Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology; Public Workshop , hisani.madison@fda.hhs.gov Peggy.Roney@fda.hhs.gov https://collaboration.fda.gov/common/help/en/support/meeting_test.htm https://www.adobe.com/go/connectpro_overview https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm https://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/default.htm https://www.regulations.gov Vol. 82, no. 227 Office of the Federal Register, National Archives and Records Administration 2017-11-28 continuing daily deposited born digital 387 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2017-11-28 P0b002ee1979fb347 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr28no17 https://www.govinfo.gov/app/details/FR-2017-11-28 https://www.govinfo.gov/content/pkg/FR-2017-11-28/pdf/FR-2017-11-28.pdf https://www.govinfo.gov/content/pkg/FR-2017-11-28/xml/FR-2017-11-28.xml fdlp 56151 56527 DGPO 2017-11-28 2024-06-01 FR-2017-11-28 machine generated eng FR FR-2017-11-28 82 227